The Journey to an RSV Vaccine.

CONCLUSION: Over the past decade there have been significant advances in our knowledge of RSV molecular and structural biology, and in understanding the human immune response to RSV. Despite the barriers, there are several promising monoclonal antibodies and RSV vaccines undergoing clinical trials that hope to offer protection to the most vulnerable populations. PMID: 32217187 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Ann Allergy Asthma Immunol Source Type: research